Fresenius Medical Care Scheduled to Report Q3 2026 Earnings
Fresenius Medical Care (FMS) is set to release its third-quarter 2026 financial results on Tuesday, November 3rd, prior to the market opening. Market analysts have established a consensus earnings per share (EPS) estimate of €1.20 and a revenue projection of €4.91 billion. The upcoming report follows a period of mixed sentiment for the dialysis provider, as recent discussions have centered on margin expansion versus limited growth prospects. Additionally, the company faces external regulatory pressures following news that the U.S. Department of Health and Human Services (HHS) is seeking reforms within the dialysis market.
Topics: dialysis market earnings announcement financial estimates